发明公开
EP2470200A1 CYTOTOXIC T-LYMPHOCYTE-INDUCING IMMUNOGENS FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF CANCER 有权
细胞毒性T淋巴细胞诱导免疫原性预防,治疗和诊断的意义

  • 专利标题: CYTOTOXIC T-LYMPHOCYTE-INDUCING IMMUNOGENS FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF CANCER
  • 专利标题(中): 细胞毒性T淋巴细胞诱导免疫原性预防,治疗和诊断的意义
  • 申请号: EP10812453.8
    申请日: 2010-06-13
  • 公开(公告)号: EP2470200A1
    公开(公告)日: 2012-07-04
  • 发明人: PHILIP, Ramila
  • 申请人: Immunotope, Inc.Philip, Ramila
  • 申请人地址: The Pennsylvania Biotechnology Center 380 Old Easton Road Doylestown, PA 18902 US
  • 专利权人: Immunotope, Inc.,Philip, Ramila
  • 当前专利权人: Immunotope, Inc.,Philip, Ramila
  • 当前专利权人地址: The Pennsylvania Biotechnology Center 380 Old Easton Road Doylestown, PA 18902 US
  • 代理机构: Casley, Christopher Stuart
  • 优先权: US236969P 20090826
  • 国际公布: WO2011025572 20110303
  • 主分类号: A61K39/00
  • IPC分类号: A61K39/00
CYTOTOXIC T-LYMPHOCYTE-INDUCING IMMUNOGENS FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF CANCER
摘要:
The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as lung carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against lung and other cancers.
信息查询
0/0